Therefore, diabetes-associated targets (AKT1 and PPARγ) and two targets involved in regulating glucolipid metabolism (GSK3β and ADORA1), which have the lowest free energy binding with their compounds, were selected for molecular docking and refined by exploring the specific binding sites. Here, ADORA1 is linked to diabetes mellitus.